Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2002
02/13/2002EP1178801A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
02/13/2002EP1178797A1 Inhibitors of impdh enzyme
02/13/2002EP1178794A1 Use of succinic acid derivatives to obtain a medicine for treating inflammation
02/13/2002EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response
02/13/2002EP1178781A1 Multilayer pharmaceutical product for release in the colon
02/13/2002EP1105382B1 Method for the preparation of citalopram
02/13/2002EP1042320B1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
02/13/2002EP0861081B1 Use of epinastine in the treatment of pain
02/13/2002EP0737199B1 Method for preparing concentrated biologically active silicon compounds
02/13/2002CN1335881A UME extract having medicinal effects and compositions containing the same
02/13/2002CN1335853A Alpha v beta b integrin inhibitors
02/13/2002CN1335849A Pyrrolopyrimidines as protein kinase inhibitors
02/13/2002CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them
02/13/2002CN1335838A Pyrimidine compounds
02/13/2002CN1335779A The preparation and use of radium-223 to target calcified tissues for pain palliation bone cancer therapy, and bone surface conditioning
02/13/2002CN1335775A Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation and cyclooxygenase enzymes
02/13/2002CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
02/13/2002CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent
02/13/2002CN1335176A Chinaroot greenbrier rhizome extract and its prepn process
02/13/2002CN1335175A Chinese medicine prepn
02/13/2002CN1335171A Gynopathy treating Chinese medicine with functions of diminishing inflammation and eliminating spot and its prepn
02/13/2002CN1335153A Veterinary compound antibiotic prepn and its prepn process
02/13/2002CN1335151A Medicine bolus for treating numbness and pain
02/13/2002CN1335145A External-use plaster for softening dry feces and dissipating mass
02/13/2002CN1335139A Compounding process of pain relieving and inflammation diminishing ointment
02/12/2002US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/12/2002US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
02/12/2002US6346278 Lipid extract of perna or mytilus
02/12/2002US6346275 Drugs for immunology residues of corallinaceae, seaweed derivatives
02/12/2002US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin
02/12/2002US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
02/12/2002CA2227194C Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]
02/12/2002CA2110273C Benzimidazole derivatives, their preparation process and their use in the fields of therapeutics and cosmetics
02/12/2002CA2088742C Benzimidazole and imidazopyridine derivatives and their application
02/12/2002CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
02/12/2002CA2066491C Human neurokinin-1 receptor
02/07/2002WO2002010410A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
02/07/2002WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
02/07/2002WO2002010405A2 A human disintegrin protein
02/07/2002WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
02/07/2002WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
02/07/2002WO2002010387A2 G-protein coupled receptors
02/07/2002WO2002010363A2 Protein phosphatases
02/07/2002WO2002010357A2 Gsk3 polypeptides
02/07/2002WO2002010217A2 Endothelial cell expression patterns
02/07/2002WO2002010216A2 Proteins and nucleic acids encoding same
02/07/2002WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof
02/07/2002WO2002010192A2 Somatostatin analogues
02/07/2002WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion
02/07/2002WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
02/07/2002WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
02/07/2002WO2002010161A1 Process for preparing arylacetylaminothiazoles
02/07/2002WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
02/07/2002WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002WO2002010143A1 Non-steroidal inflammation inhibitors
02/07/2002WO2002010140A2 Imidazolyl derivatives
02/07/2002WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase
02/07/2002WO2002010137A2 Indazole derivatives as jnk inhibitors
02/07/2002WO2002010136A1 3-substituted isoquinolin-1-yl derivatives
02/07/2002WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
02/07/2002WO2002009768A2 Therapeutic polyesters and polyamides
02/07/2002WO2002009731A1 Use of co for treating inflammation of upper airways or bronchi
02/07/2002WO2002009707A1 Fentanyl composition for nasal administration
02/07/2002WO2002009701A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis
02/07/2002WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
02/07/2002WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients
02/07/2002WO2002009637A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
02/07/2002WO2001081310A8 1-aroyl-piperidinyl benzamidines
02/07/2002WO2001070130A3 Compositions derived from modiolus modiolus and methods for making and using same
02/07/2002WO2001059127A3 Drug metabolizing enzymes
02/07/2002WO2001046218A3 Fragments of pf4 and pharmaceutical compositions containing the same
02/07/2002WO2001044294A3 Compositions and methods for inhibiting endothelial cell proliferation
02/07/2002WO2001030333A3 Tissue factor antagonists and methods of use thereof
02/07/2002US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease
02/07/2002US20020016471 Inhibitors of p38
02/07/2002US20020016465 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
02/07/2002US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent
02/07/2002US20020016351 New crystals of celecoxib
02/07/2002US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha
02/07/2002US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
02/07/2002US20020016343 Selective cyclooxygenase-2 inhibitor, useful in treatment of inflammation, pain and fever
02/07/2002US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
02/07/2002US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease
02/07/2002US20020016331 Method of treating pain using nalbuphine and opioid antagonists
02/07/2002US20020016328 Corticotropin releasing factor antagonists
02/07/2002US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use
02/07/2002US20020016321 Novel tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
02/07/2002US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
02/07/2002US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer
02/07/2002US20020015735 Oral administering
02/07/2002US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease
02/07/2002US20020015701 Inhibiting properdin-induced stabilization of C3 convertase by exposure to an anti-properdin antibody
02/07/2002US20020015700 Inhibiting the interaction of a cell bearing mammalian chemokine receptor 2 (CCR2) with a ligand by binding with antibodies or functional fragments
02/07/2002DE10037146A1 Acetamidderivate Acetamide derivatives
02/07/2002DE10036852A1 Urethanderivate Urethane
02/07/2002DE10036818A1 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten New N-triazolylmethyl piperazine derivatives as neurokinin receptor antagonists
02/07/2002DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives
02/07/2002CA2771263A1 Therapeutic polyesters and polyamides
02/07/2002CA2418120A1 High affinity integrin polypeptides and uses thereof
02/07/2002CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof